TEVA
Teva Pharmaceutical Industries Limited
NYSE · ILHealthcareDrug Manufacturers - Specialty & Generic
$31.00-3.22%
Price as of Jul 20, 2026
TEVA profitability
Teva Pharmaceutical Industries Limited profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 52.1%
- EBITDA margin
- 18.8%
- EBIT margin
- 13.2%
- Net margin
- 9.0%
- Free cash flow margin
- 6.8%
Returns
- Return on equity
- 19.0%
- Return on assets
- 3.9%
- Return on invested capital
- 9.1%
- Asset turnover
- 0.43x
Cash efficiency
- Cash from operations
- $1.7B
- Cash per share
- $3.21
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.